Alloy Therapeutics, a biotechnology ecosystem company and Wheeler Bio, a contract development and manufacturing organization (CDMO), will form a non-exclusive, preferred service offering to drive translation from discovery to CMC development and clinical material supply for ecosystem partners. The organizations are collaborating to provide a service experience for Alloy partners requiring CMC development services from Wheeler as a reliable CMC service provider for development and GMP manufacturi...